Astera Labs (NASDAQ:ALAB) Stock Price Down 1.8% – Should You Sell?

Shares of Astera Labs, Inc. (NASDAQ:ALAB) traded down 1.8% during trading on Friday . The stock traded as low as $329.61 and last traded at $343.05. 5,959,902 shares changed hands during mid-day trading, an increase of 7% from the average session volume of 5,547,847 shares. The stock had previously closed at $349.17.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Stifel Nicolaus raised their target price on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Morgan Stanley raised their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. TD Cowen raised their target price on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Finally, Loop Capital assumed coverage on Astera Labs in a research report on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Stock Performance

The company’s 50 day moving average price is $186.48 and its 200 day moving average price is $163.86. The company has a market cap of $58.80 billion, a price-to-earnings ratio of 231.79, a P/E/G ratio of 4.31 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the company earned $0.33 EPS. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares in the company, valued at $30,075,913.29. This represents a 0.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 2,316,257 shares of company stock worth $474,860,636. Corporate insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Institutional investors and hedge funds have recently made changes to their positions in the company. Assetmark Inc. raised its holdings in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Reflection Asset Management bought a new position in shares of Astera Labs in the fourth quarter valued at about $25,000. Smartleaf Asset Management LLC raised its holdings in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank raised its holdings in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC bought a new position in shares of Astera Labs in the fourth quarter valued at about $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.